 _v4.jpg)
_BMT.png)
Report Library
View More
Datamonitor Healthcare Oncology: HR...
October 16, 2018
Datamonitor Healthcare Oncology: Br...
October 16, 2018
Datamonitor Healthcare Type 2 Diabe...
October 12, 2018
Datamonitor Healthcare Type 2 Diabe...
October 12, 2018
Datamonitor Healthcare Type 2 Diabe...
October 12, 2018
Datamonitor Healthcare CV&Met: Coro...
October 12, 2018
Datamonitor Healthcare Oncology: My...
October 12, 2018
Datamonitor Healthcare CNS: Hunting...
October 12, 2018
Datamonitor Healthcare PharmaVitae:...
October 10, 2018
The Latest in Immuno-Oncology: A De...
October 9, 2018
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 10/16/18 | Shire (SHPG) | SHP555 for Chronic Idiopathic Constipation | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/16/18 | Pfizer (PFE) | Talzenna for Breast Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/16/18 | Allergan (AGN) | Liletta for Contraception | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/16/18 | Regeneron (REGN) | Dupixent for Nasal Polyposis | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/16/18 | Kala (KALA) | KPI-121 0.25% for Dry Eye (Ophthalmology) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 10/17/18 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 10/17/18 | Subscribers Only | Subscribers Only | Regulatory - FDA Advisory Panel Meeting |
| 10/17/18 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 10/17/18 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 10/17/18 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
